Dr. McGilvray studied medicine at McGill University, graduating in 1993. He entered the General Surgery training program at the University of Toronto that same year. During his residency, he undertook graduate studies in Dr. Ori Rotstein’s laboratory and obtained a PhD in Cell Biology. He became a Fellow of the Royal College of Physicians and Surgeons of Canada in 2001. After a clinical fellowship in Transplantation and Hepatobiliary Surgery at the Toronto General Hospital, he began his appointment at the University Health Network in 2003. He is currently an Associate Professor in the Department of Surgery at the University of Toronto.
- Diseases of the liver, particularly viral hepatitis
- Transplant immunology
- Hepatic ischemia/reperfusion injury
- Vascular reconstructive techniques for locally advanced liver and pancreas cancer
- Applicability of transplantation to oncology diagnoses
Routine induction therapy in living donor liver transplantation prevents rejection but may promote recurrence of hepatitis C.
Transplant Proc. 2012 Jun;44(5):1351-6
Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype.
Gastroenterology. 2012 May;142(5):1122-1131.e1
Comparison of outcomes and costs between laparoscopic distal pancreatectomy and open resection at a single center.
Surg Endosc. 2012 May;26(5):1220-30
Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
Liver Transpl. 2012 Mar;18(3):315-22
Am J Transplant. 2012 Jan;12(1):226-32
Surgical revision of biliary strictures following adult live donor liver transplantation: patient selection, morbidity, and outcomes.
Transpl Int. 2012 Jan;25(1):69-77
Thymoglobulin versus basiliximab induction therapy for simultaneous kidney-pancreas transplantation: impact on rejection, graft function, and long-term outcome.
Transplantation. 2011 Nov 15;92(9):1039-43
Liver Transpl. 2011 Dec;17(12):1404-11
FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice.
J Hepatol. 2012 Jan;56(1):153-9
The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy.
Int J Biochem Cell Biol. 2011 Oct;43(10):1427-31
Senior Scientist, Toronto General Hospital Research Institute (TGHRI)
Associate Professor, Department of Surgery, Faculty of Medicine, University of Toronto